Diane Weiser | VP, Corporate Communications and IR |
Robert Blum | President and CEO |
Fady Malik | EVP, Research and Development |
Andy Wolff | SVP and Chief Medical Officer |
Robert Wong | VP and Chief Accounting Officer |
Ching Jaw | SVP and CFO |
Joe Pantginis | H.C. Wainwright |
Jason Butler | JMP Securities |
Chad Messer | Needham & Company |
Ted Tenthoff | Piper Jaffray |
Jeff Hung | Morgan Stanley |
Good afternoon and welcome ladies and gentlemen to the Cytokinetics' Second Quarter 2019 Conference Call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode. At the request of the company, we will open the call for questions-and-answers after the presentation.
I will now turn the call over to Diane Weiser, Cytokinetics' Vice President of Corporate Communications and Investor Relations. Please go ahead.